Trans Anal Surgery for Cancer and Bowel Dysfunction

Transanal procedures encompass a wide family of surgical and therapeutic techniques that access the pelvic organs through the anus rather than through abdominal incisions. They range from local excision of small rectal tumors to full cancer operations, from pediatric reconstructions for congenital bowel conditions to irrigations that manage chronic bowel dysfunction. The common thread is the route: working from below, through the body’s natural opening, to reach structures that once required major open surgery. Over the past four decades, this approach has reshaped colorectal care in ways that affect millions of patients each year.

How Transanal Surgery Evolved

The modern era of transanal surgery traces back to the work of German surgeon Gerhard Buess, who introduced transanal endoscopic microsurgery (TEM) in the early 1980s. TEM used a specialized rigid operating scope inserted through the anus, combined with magnified video and carbon dioxide insufflation, to give surgeons a clear, stable view of rectal lesions that were previously impossible to reach without opening the abdomen. That platform proved the concept: you could perform precise, full-thickness excisions of rectal tumors from below with excellent visualization.¹

From TEM, the field branched in several directions. Laparoscopic instruments arrived in the 1980s and 1990s, and surgeons quickly adapted the minimally invasive platform to transanal work. Over the following three decades, advances in video systems, instrument design, perioperative care, and robotics expanded what could be done through the anal canal.² The culmination of these parallel tracks was transanal total mesorectal excision (taTME), a technique for removing the entire rectum and its surrounding fatty envelope for cancer, performed partly or entirely from below. taTME drew on lessons from TEM, laparoscopy, and even experimental natural-orifice surgery to become one of the most discussed innovations in colorectal surgery of the past decade.³

Local Excision of Early Rectal Tumors

For small, early-stage rectal tumors, the transanal route often means the difference between keeping your rectum and losing it. Traditional surgery for rectal cancer involves removing the entire rectum, which carries real consequences for bowel function, sexual function, and sometimes means a permanent stoma. If a tumor is caught early enough and has favorable features, a surgeon can instead excise just the tumor through the anus, leaving the rectum intact.

TEM became the gold standard for this kind of local excision. Compared with older transanal techniques that relied on retractors and headlamps, TEM offered superior visualization, better access to tumors higher up in the rectum, lower rates of positive margins, less specimen fragmentation, and lower long-term recurrence rates.⁴ A newer variant called transanal minimally invasive surgery (TAMIS) uses a flexible single-port device rather than TEM’s rigid scope. TAMIS has gained popularity because its setup is simpler and less expensive, making it more accessible to hospitals that cannot justify the cost of a dedicated TEM platform.⁵

An emerging strategy pairs local excision with a short course of radiation to push the concept of organ preservation even further. A randomized feasibility trial found that short-course radiotherapy followed by TEM achieved high levels of organ preservation with relatively low complication rates and signs of improved quality of life compared with radical surgery. The researchers concluded this approach deserves further evaluation, both for patients who are too frail for major surgery and for those who are fit but want to keep their rectum.⁶

Transanal Total Mesorectal Excision for Rectal Cancer

When rectal cancer is too advanced for local excision, the standard operation is total mesorectal excision, which removes the rectum along with its mesorectal fat envelope in one intact package. Doing this laparoscopically (from above) can be technically brutal in a narrow, deep pelvis, especially in obese men or patients with bulky low tumors. taTME flips the approach: the surgeon begins the dissection from the anal side, working upward through the planes around the tumor where visibility is best, then meets the abdominal team coming down from above.

Meta-analyses comparing taTME with conventional laparoscopic TME have found several consistent advantages. One pooled analysis of randomized trials showed that adding transanal dissection dropped the rate of conversion to open surgery dramatically, and patients were more likely to achieve a complete mesorectal excision. Complication rates, operative times, anastomotic leak rates, and margin positivity were statistically similar between the two approaches.⁷ A separate meta-analysis found that taTME was associated with a higher rate of clear resection margins and more lymph nodes harvested, along with a much lower conversion rate to open surgery.⁸

Those findings matter because clear margins and an intact mesorectal envelope are among the strongest predictors of long-term cancer outcomes after rectal surgery. If the dissection wanders into the wrong plane, or the specimen is fragmented, recurrence risk rises. The transanal approach gives the surgeon a direct view of the most challenging part of the dissection, which is at the pelvic floor, and that visual advantage appears to translate into better specimen quality in pooled data.

The Learning Curve Problem

taTME is not easy to learn. The anatomy looks unfamiliar from below, and the planes that guide the dissection run differently than what surgeons are accustomed to from the abdominal perspective. Key landmarks include the endopelvic fascia behind the rectum, the pelvic nerves along the sides, and the prostate or posterior vaginal wall in front. Getting the dissection layer right depends on tumor depth and a precise understanding of the layered pelvic fascia.⁹ MRI-based studies have helped define additional landmarks: the seminal vesicles in men, the cervix in women, and the junction of the anococcygeal ligament and coccyx in the back.¹⁰

A single-center study from China quantified the learning curve by tracking outcomes across consecutive cases. A surgeon needed roughly 42 cases to bring operative time to a stable plateau, about 75 cases before complication rates leveled off, and around 68 cases to reach a stable anastomotic leak rate. The authors suggested that 42 cases represented “proficiency” and 75 cases represented “mastery.”¹¹ Those are large numbers by surgical training standards. A systematic review focused specifically on taTME complications emphasized that perioperative problems deserve close scrutiny during the early implementation phase, precisely because the procedure is hard to master.¹²

Functional Outcomes and Quality of Life After Cancer Surgery

Removing a rectum for cancer, by any technique, carries a real cost in daily bowel function. A condition called low anterior resection syndrome (LARS) affects many patients who have sphincter-preserving rectal cancer surgery, causing urgency, clustering of bowel movements, and episodes of incontinence. The question for taTME is whether going through the anus makes these symptoms worse than a purely abdominal approach.

An updated meta-analysis pooling quality-of-life data from multiple studies found no significant difference between taTME and laparoscopic TME on standardized measures of anorectal function, including LARS scores and fecal incontinence scores. Quality-of-life questionnaire results were also similar, and there was no difference in urinary or sexual function between the two approaches.¹³ Individual studies have painted a slightly more nuanced picture. One comparison found that while overall global health status and total LARS scores were similar, patients in the taTME group reported more buttock pain, diarrhea, stool clustering, and urgency. Interestingly, those same patients reported higher satisfaction with urinary function.¹⁴ Another study found equivalent quality-of-life scores on most measures but a slightly worse fecal incontinence score for taTME.¹⁵

For local excision with TEM, the functional story is more reassuring. Despite the fact that TEM requires inserting a large rigid scope that dilates the anal canal, a study measuring fecal incontinence scores before and after TEM found no deterioration, and quality of life related to continence actually improved, likely because the tumor itself had been causing symptoms.¹⁶ The broader principle is well established: non-sphincter-sparing anal surgery leads to internal sphincter injury and incontinence, so modern approaches aim to preserve the sphincter complex whenever possible.¹⁷

Pediatric Transanal Procedures

In children, the most prominent transanal operation is the endorectal pull-through for Hirschsprung’s disease, a congenital condition where nerve cells are missing from a segment of the bowel, leaving it unable to relax and pass stool. The traditional repair involved opening the abdomen, but transanal endorectal pull-through (TEPT) allows the aganglionic bowel to be removed and healthy bowel pulled down to the anus entirely from below. Studies have shown this single-stage transanal approach is feasible, safe, and effective across all ages of children with the typical rectosigmoid form of the disease.¹⁸ More recent work continues to assess long-term complications and bowel function after TEPT, with a focus on quality of life in the growing child.¹⁹

One critical lesson from pediatric experience is how much the anal canal matters. When the pull-through procedure damages the anal canal, incontinence is severe and likely permanent.²⁰ For low anorectal malformations, the surgical philosophy similarly emphasizes minimally invasive methods and preservation of the native continence mechanisms, which are typically better preserved in these milder anomalies than in more severe high malformations.²¹

Transanal Treatment of Hemorrhoids and Rectocele

Beyond cancer and congenital conditions, transanal techniques have transformed the management of common benign anorectal problems. Doppler-guided hemorrhoidal dearterialization (also called transanal hemorrhoidal dearterialization, or THD) uses a special ultrasound probe inserted through the anus to locate the arteries feeding the hemorrhoidal tissue. The surgeon then ties off those arteries, and if there is prolapsing tissue, stitches it back into place with a mucopexy. A 20-year literature review found this approach safe and effective for grades II through IV hemorrhoidal disease, with satisfactory results even in patients with prolapse. Disturbances to anal function were rare and mostly temporary, making the technique especially attractive for patients who have had prior anal surgery or who already have borderline continence.²² Long-term follow-up confirms that most patients see resolution of symptoms after the combined dearterialization and mucopexy procedure.²³ A study measuring anal function before and after THD found that sphincter length was unchanged and no patients developed fecal incontinence or anal narrowing.²⁴

Rectocele, a condition in which the front wall of the rectum bulges into the vagina causing obstructed defecation, can also be repaired transanally. A technique called TRREMS uses a circular stapler inserted through the anus to simultaneously repair the rectocele and remove excess prolapsing rectal mucosa. Early results showed correction of the rectocele on imaging and resolution of obstructed defecation in all treated patients.²⁵ Longer follow-up of the TRREMS technique confirmed satisfactory anatomic and functional results with low rates of pain and complications.²⁶

Transanal Irrigation for Bowel Dysfunction

Not all transanal therapies are surgical. Transanal irrigation (TAI) is a non-operative technique in which water is introduced into the colon and rectum through a catheter placed in the anus, promoting controlled evacuation of stool. It was originally developed for patients with neurogenic bowel dysfunction, such as those with spinal cord injuries, where the nerves that coordinate defecation no longer work properly.²⁷ More recently, TAI has found a major role in managing LARS after rectal cancer surgery.

A randomized controlled trial comparing TAI with conservative treatment in patients with LARS found that at one year, patients using irrigation had significantly lower LARS scores and fecal incontinence scores, along with significantly better quality of life on multiple measures.²⁸ A study of patients discharged after irrigation training showed dramatic improvement: at baseline, about two-thirds had major LARS, but at discharge, 80% reported no LARS at all, with the average LARS score dropping by roughly two-thirds. Most patients continued to irrigate beyond the study period because they found ongoing benefit.²⁹ Long-term Italian data showed that these improvements hold up over two years. At the start, about 85% of patients had major LARS; by two years, that figure had dropped to under 17%, and the average number of symptomatic episodes fell from just over 4 per patient to half of one. The dropout rate was low, under 9% at two years.³⁰

Safety Concerns With Transanal Irrigation

TAI is generally safe, but it is not risk-free. The most feared complication is bowel perforation. A global audit of the Peristeen irrigation system identified 49 reported perforations. Based on sales data, that worked out to about 6 perforations per million procedures on average, and the most recent data showed the risk had fallen to about 2 per million. About two-thirds of perforations happened within the first eight weeks of use, after which the long-term risk settled below 2 per million. Among patients with non-neurogenic bowel dysfunction, a history of prior pelvic surgery was a major risk factor: nearly three-quarters of those patients had undergone previous pelvic surgery, compared with fewer than one in five in the neurogenic group.³¹ A separate long-term safety study found just two non-fatal perforations among roughly 110,000 irrigation procedures.³²

The practical takeaway is that perforation risk is concentrated in the early learning period and in patients whose rectal anatomy has been altered by previous surgery. A case report described perforation in a LARS patient, underscoring that different catheter types and insertion techniques can influence the risk.³³ Careful patient selection, thorough evaluation of anatomy before starting, and proper training are all critical to keeping this therapy safe.

Salvage and Emergency Uses

Transanal access has also proven useful in situations that go wrong after colorectal surgery. When an anastomotic leak creates a pelvic abscess or cavity after rectal resection, reoperation through the abdomen is high risk and may mean a permanent stoma. Transanal vacuum therapy, in which a sponge device is placed into the leak cavity through the anus and connected to negative-pressure suction, has emerged as a way to close these cavities without major reoperation. Early experience suggested this approach effectively promotes cavity closure, reduces the need for a permanent stoma, and results in acceptable bowel function.³⁴

Similarly, pelvic abscesses that form after procedures like Hartmann’s operation can be drained through the rectum using TEM instruments. This endoscopic approach allows not just drainage but also direct visualization of the abscess cavity, breaking up of walled-off pockets, and saline irrigation, all without an abdominal incision.³⁵

Imaging Before Transanal Surgery

Preoperative imaging plays a central role in planning transanal operations, particularly for rectal tumors. MRI of the pelvis has become the dominant modality for staging rectal cancer, providing detailed views of the tumor’s depth, its relationship to the mesorectal fascia, and the status of regional lymph nodes. Endoanal ultrasound, which uses a small probe inserted through the anus, offers a complementary view and is preferred by some clinicians specifically when planning local excisions, where a detailed picture of wall-layer invasion determines whether a transanal approach is appropriate.³⁶ One advantage of newer three-dimensional endorectal ultrasound and endorectal MRI techniques is the ability to generate multiplanar images, which may further refine surgical planning.³⁷

Robotic Platforms and the Transanal Frontier

Robotics represents the newest layer of technology applied to transanal surgery. Robotic transanal minimally invasive surgery (R-TAMIS) uses the articulated arms of a surgical robot, docked to a transanal port, to perform local excisions with three-dimensional magnified visualization, motion scaling, and improved ergonomics. Early experience centered on the da Vinci Si system, which was limited by bulky arms and awkward docking in the confined space of the rectum. The subsequent Xi platform addressed many of these issues with slimmer arms and better access.³⁸ Whether the added cost and complexity of a robot translates into better outcomes for transanal local excision remains an open question. The theoretical benefit is greatest for anatomically challenging lesions, particularly those higher in the rectum or in curved segments where rigid instruments struggle. As robotic platforms become smaller and more versatile, their role in transanal surgery is likely to expand, though evidence comparing robotic and conventional TAMIS outcomes at scale is still limited.